Lipstein Ellen A, Dodds Cassandra M, Lovell Daniel J, Denson Lee A, Britto Maria T
Center for Innovation in Chronic Disease Care, Division of Adolescent Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
James M. Anderson Center for Health Systems Excellence, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Health Expect. 2016 Jun;19(3):716-26. doi: 10.1111/hex.12210. Epub 2014 Jun 3.
To compare factors considered by parents to those considered by adolescents making decisions about chronic disease treatments.
We conducted individual interviews with 15 parent-adolescent dyads in which the adolescent had either juvenile idiopathic arthritis or Crohn's disease. Questions focused on treatment decisions, with an emphasis on the factors that influenced each individual's preferences related to biologic therapies. A multidisciplinary team developed a coding structure. All interviews were coded by two people with disagreements resolved through discussion. We used content analysis and coding matrices to examine decision factors within and between parent-adolescent dyads.
Parents and adolescents both participated in decisions about treatment with biologic therapies but considered decision factors differently. In only half of cases did parents and adolescents agree on the factor that most influenced their decision. Although their decision factors often fell into similar categories (e.g. treatment risks, quality of life), in many cases the specifics varied between adolescents and their parents. Adolescents were more likely to focus on immediate treatment effects and quality of life while parents took a longer term view of the decision. Agreement within dyads was most consistent when a special circumstance influenced the treatment decision.
Differences regarding influential decision factors exist within parent-adolescent dyads. Continued research is needed to determine the extent to which such differences are due to individual preferences or to variations in the information available to each person. Future decision support interventions will need to address parents' and adolescents' potentially disparate views and information needs.
比较在做出慢性病治疗决策时,父母与青少年所考虑的因素。
我们对15对父母-青少年组合进行了个体访谈,这些青少年患有青少年特发性关节炎或克罗恩病。问题聚焦于治疗决策,重点是影响每个人对生物疗法偏好的因素。一个多学科团队制定了编码结构。所有访谈由两人进行编码,分歧通过讨论解决。我们使用内容分析和编码矩阵来检查父母-青少年组合内部和之间的决策因素。
父母和青少年都参与了生物疗法治疗决策,但考虑的决策因素不同。只有一半的情况下,父母和青少年在最影响他们决策的因素上达成一致。尽管他们的决策因素通常属于相似类别(如治疗风险、生活质量),但在许多情况下,青少年和他们父母之间的具体情况有所不同。青少年更可能关注即时治疗效果和生活质量,而父母对决策持更长远的观点。当特殊情况影响治疗决策时,组合内部的一致性最为一致。
父母-青少年组合在有影响力的决策因素方面存在差异。需要持续研究以确定这种差异在多大程度上是由于个人偏好或每个人可获得信息的差异。未来的决策支持干预措施将需要解决父母和青少年潜在的不同观点和信息需求。